Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hannah Daniel

Reporter

Having recently joined the team in 2022, Hannah Daniel is a reporter for Medtech Insight. She is interested in following Rx-to-OTC drug switches and investigating developments from clinical trials. She is the host for HBW’s Over the Counter Podcast U.S. and holds a bachelor’s degree in biology from Carnegie Mellon University.

Latest From Hannah Daniel

CDC Chooses Five Laboratories For Pathogen Genomics Network

The CDC’s $90m funding will be split among five laborites across the US over five years as a part of its pioneering Pathogen Genomics Centers of Excellence Network.

Policy Coronavirus COVID-19

Software Pre-Certification Program Highlights Needs For Legislative Change, FDA Says

In a report published September 26, the FDA released the findings from its software pre-certification program which include the need for a new regulatory authority to supplement current regulations for medical devices.

Legislation FDA

Novel Negative Pressure Wound Therapy System Cleared By FDA

The FDA granted 510(k) clearance to Applied Tissue Technologies for its non-foam negative pressure wound therapy system. 

Approvals Regulation

Fewer Than Half Of Children On Medicaid Receive Life-Saving Sickle-Cell Screenings, CDC Says

A CDC study found that fewer than half of children with sickle cell disease were getting screened for strokes, and fewer than 40% of children were taking recommended medications.  

Research & Development Consumer

Biden Issues Biotechnology Executive Order To Spur Research And Development

Summary: President Biden signed Executive Order 14081 to boost biotech R&D and provide regulatory clarity to industry.

Legislation Policy

Medtronic Insulin Pumps Vulnerable To Cybersecurity Attacks

Medtronic’s MiniMed series insulin pumps could allow unauthorized hackers to change the amount of insulin delivered to a patient, the FDA says. 

Recalls Cybersecurity
See All
UsernamePublicRestriction

Register